Advocating for a cure for Herpes Simplex Virus.
Join us for a focused discussion on advancing herpes cure advocacy through education, collaboration, and idea-sharing. Open to all advocates, researchers, and supporters looking to make a meaningful impact. No pre-registration required. https://us06web.zoom.us/j/85288719587
Put on by the University of Pennsylvania School of Medicine, this symposium is one day (8am to 5pm) and is free for all participants. There is no registration fee but individual attendees have to register so they can obtain a head count. More details soon.
View Recording Dr. Marius Walter is a virologist and molecular biologist at the Fred Hutch Cancer Center in Seattle, WA. His research focuses on herpesviruses and invented a new therapeutic strategy against herpesviruses, using engineered “gene drive” viruses that can replace wild-type viruses with an attenuated version to potentially reduce viral levels and suppress symptoms.Continue reading "HSV Updates – Fred Hutch"
The International Society for Sexually Transmitted Diseases Research (ISSTDR) exists to promote research on sexually transmitted diseases and facilitate the timely exchange of information among research investigators. To these ends, ISSTDR sponsors a biennial, interdisciplinary scientific meeting, at venues that historically have alternated between Europe and North America. During the three decades since the SocietyContinue reading "STI & HIV World Congress 2025"
The International Herpesvirus Workshop (IHW) is an annual conference where researchers and experts from around the world gather to discuss the latest findings on herpesviruses. It covers a broad range of topics, including: Virus Biology and Pathogenesis: Understanding how herpesviruses work at a cellular level, how they cause disease, and how they evade the immuneContinue reading "International Herpesvirus Workshop"
Join us for a powerful and honest conversation bridging the gap between healthcare professionals and the herpes patient community. This unique panel brings together leading voices in HSV education, advocacy, and care: Terri Warren, RN, ANP – Renowned herpes expert and longtime sexual health provider. Dr. Ina Park, MD, MS – Physician, author, and advocateContinue reading "HSV Patient-Provider Panel"
Advancing Science is a meeting series in a partnership between Herpes Cure Advocacy and HVTN to highlight the latest science in herpes, projects that are driving the field of HSV research forward amongst professionals and scientists. The target audience for this talk is scientists and medical professionals. Guest Speaker Name and Title: Dr. David LeibContinue reading "Therapy and prevention of long-term cognitive impairment following neonatal herpes simplex virus infections"
David Camerini is the Director of Virology at ImmPORT Therapeutics/DBA Antigen Discovery Register Here
We frequently hear about breakthrough discoveries and promising results for new antiherpetic drugs, only to hear nothing more about them afterward. Promising therapies are announced, followed by long periods of silence. Why don't these promising drugs reach the market? Why does drug development take so long? Is there a way to accelerate the process? WhereContinue reading "From discovery to cure: the complex path of antiherpetic drug development"
Join us as we host Assembly Bio for an in-depth discussion on recurrent genital herpes (RGH). This talk will provide an overview of RGH epidemiology, real-world disease burden, and impact on affected individuals. We will review the current treatment landscape and patient journey, highlight the state of clinical science, and discuss the rationale for advancingContinue reading "Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation."
Despite the fact that 48% of people between 14 and 49 in the US are infected with HSV 1, and one in eight adults is infected with HSV-2, many peopleContinue reading "How Clinicians and Patients Talk about Herpes: Bridging the Disconnect"
Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccineContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"